Aurobindo Pharma arm, CuraTeQ Biologics, enters into exclusive license agreement with BioFactura Inc, USA to commercialise BFI-751, a proposed biosimilar to Stelara (Ustekinumab)


ITC issues clarification on reports of demerger of the hotel business. The company says that it is committed to implementing its ‘asset-right’ strategy with respect to the hotels business

Gland Pharma gets USFDA nod fFor Fomepizole’s Abbreviated New Drug Application (ANDA)

RVNL emerges as lowest bidder for a NHAI project worth Rs 808.48 cr

ZydusLife's US FDA concludes pre-approval inspection with Zero observations for ZydusLife's Ahmadabad-based formulation manufacturing facility at SEZ 2

M&M issues clarification on market rumour of potential investors’ infusion of Rs 6,000 cr in EV business

AurobindoPharma arm gets exclusive rights for BioFactura's monoclonal antibody ustekinumab biosimilar

Hindustan Zinc declares an interim dividend of Rs 7 per share

Gujarat Alkalies dispatches first consignment of purified phosphoric acid (85%) from the Dahej facility

HDFCBank to report Q1FY24 earnings on July 17
HDFC Bank to be added to MSCI Global Index from July 13

PHOENIX MILLS
Q1 UPDATE
Total Consumption Up 18% (YoY) At Rs 2,574.5 Cr
Retail Collections At Rs 621.1 Cr, Up 18% (YoY)

JK CEMENTS
ACQUISITION UPDATE
Arm JK Maxx Paints Acquires 20% Stake Of Acro Paints For Rs 60.24 Crores

NTPC
PLANT UPDATE
Completes Trial Operation By 660 MW Capacity Unit Of Barh Super Thermal Power Project

PRISM JOHNSON
Boardmeet Outcome
Approves Sale Of 1,420.72 Acres Of 2 Land Parcels At Nandyal, Andhra Pradesh To RAMCO_CEMENTS
Also Approves Transfer Of Mining Lease (663 Ha in AP)

HINDUSTAN ZINC
Board Approves An Interim Dividend of Rs 7/ Share Amounting To Rs 2957.72 Crores
AwaazAlert Promoter VEDANTA Holds 274.31 Crore Shares In the company - will receive Rs 1920 Crores As Dividend Dole out

@DAYTRADERTELUGU